Reaktion #422671

ord-74622ff6de5c450cb416fb212d82cd9b

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigeIn a 5 mL seal vial
  2. 2
    Sonstigeequipped with a stir bar
  3. 3
    SonstigeThe vial was evacuated
  4. 4
    workup.ADDITIONfilled with N2
  5. 5
    workup.ADDITIONwas added into the mixture
  6. 6
    workup.ADDITIONwas added into the mixture
  7. 7
    Sonstigedried via lyophilization
  8. 8
    SonstigeThe mixture was purified with Yamazen C1 acidic condition

Vorschrift

In a 5 mL seal vial equipped with a stir bar, a septum was added (3aR,5R,6S,7R,7aR)-5-(azidomethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d][1,3]thiazole-6,7-diol (40.00 mg; 0.15 mmol; 1.00 eq.), copper Not supported by ACD (65.10 mg; 1.02 mmol; 7.00 eq.) and copper (2+) sulfate pentahydrate (7.31 mg; 0.03 mmol; 0.20 eq.). The vial was evacuated and filled with N2. This procedure was repeated for twice before ethanol (0.40 ml)/water (0.60 ml)/2-methylpropan-2-ol (1.00 ml) and 2-ethynylpyridine (0.03 ml; 0.29 mmol; 2.00 eq.) was added into the mixture. The mixture was stirred at room temperature for overnight before 3 mL H2O was added into the mixture and dried via lyophilization. The mixture was purified with Yamazen C1 acidic condition affording 14.4 mg (20.1%) of the title compound as a white solid (HPLC 99%, retention time=1.73 min) once lyophilized.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08884023B2uspto-grants-2014_11